GSK, Myungin cooperate

Published: 2010-01-13 06:58:00

Updated: 2010-01-13 06:58:00

GlaxoSmithKline has joined hands with Myungin Pharm to market Paxil controlled release (CR) tablet and Seroxat (paroxetine) tablet through the execution of a co-promotion agreement.

Under the agreement, GSK and Myung-in will be responsible for marketing Paxil in hospital and clinic sectors, r...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK